| Literature DB >> 32722706 |
Ben Niu1, Michael Martinelli Ii1, Yang Jiao1, Chunlei Wang1, Mingyan Cao1, Jihong Wang1, Eric Meinke1.
Abstract
Tryptic digestion of proteins followed by liquid chromatography with tandem mass spectrometry analysis is an extensively used approach in proteomics research and biopharmaceutical product characterization, owing to the high level of cleavage fidelity produced with this technique. However, nonspecific trypsin cleavages have been frequently reported and shown to be related to a number of digestion conditions and predigestion sample treatments. In this work, we reveal that, for a number of commercial trypsins, reconstitution and storage conditions can have a significant impact on the occurrence of trypsin nonspecific cleavages. We analyzed the tryptic digestion of a variety of biotherapeutics, using trypsins reconstituted under different conditions. The results indicate that, for many commercial trypsins, commonly recommended reconstitution/storage conditions (mildly acidic, e.g., 50 mM acetic acid, 1 mM HCl) can actually promote nonspecific trypsin activities, which are time dependent and can be as high as 20% in total relative abundance. In contrast, using water for reconstitution and storage can effectively limit nonspecific cleavages to 1%. Interestingly, the performances of different commercial trypsins were found to be quite distinct in their levels of nonspecific cleavages and responses to the two reconstitution conditions. Our findings demonstrate the importance of choosing the appropriate trypsin for tryptic digestion and the necessity of assessing the impact of trypsin reconstitution and storage on nonspecific cleavages. We advocate for manufacturers of commercial trypsins to reevaluate manufacturing processes and reconstitution/storage conditions to provide good cleavage specificity.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32722706 PMCID: PMC7386593 DOI: 10.1371/journal.pone.0236740
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1(A) Butterfly plot of UV chromatograms of mAb-A digested with Trypsin-1 reconstituted in HPLC-grade water and 50 mM acetic acid. Tryptic peptides are denoted using single letters (H = heavy chain; L = light chain) followed by the corresponding peptide number. Semitryptic and nontryptic peptides are denoted using the corresponding fully tryptic peptides that encompass their sequences, followed by Greek letters. Peaks annotated with asterisks are from autolysis. (B) Extracted ion chromatograms (XICs) of peptide H4 and the semitryptic peptides H4α, H4β, and H4γ. The abundances of semitryptic species were significantly higher when acetic acid was used for reconstitution. (C) UV peak integrals representing peptide H4 and the corresponding semitryptic peptides H4α, H4β, and H4γ showed that the sum of integrals between the two conditions were similar; however, H4α, H4β, and H4γ emerged in the acetic acid condition, at the cost of H4 signals.
Fig 2(A) XICs of NISTmAb peptide heavy chain 151–183 by monoisotopic mass (m/z 1763.8582) showed increased intensity with reconstitution in 50 mM acetic acid compared with reconstitution in water. The difference in XIC intensity between the two reconstitution conditions was more pronounced with the 4-h reconstitution period. (B) Precursor-ion spectrum of NISTmAb peptide heavy chain 151–183 (z = 2), a semitryptic peptide generated from nontryptic cleavage at Y183. (C) When 50 mM acetic acid was used for Trypsin-1 reconstitution, all four semitryptic peptides showed increasing abundances with longer reconstitution times of up to 6 h, and the corresponding two fully tryptic peptides showed decreasing abundances. With water as the reconstitution condition, the abundances of all peptides remained unchanged, and those of the four semitryptic peptides were consistently low. (D) Abundances of the four semitryptic peptides relative to their corresponding fully tryptic peptides as a function of length of reconstitution period. Orange horizontal line indicates the corresponding averaged relative abundances of each peptide with reconstitution in water.
Identification of 6 nontryptic and 52 semitryptic NISTmAb peptides with their corresponding sequences, elution times, and m/z (charge).
| Cleavage | Chain | Peptide | Sequence | RT (min) | |
|---|---|---|---|---|---|
| Nontryptic | Heavy | 28–38 | SLSTAGMSVGW | 37.0 | 1095.5138 (+1) |
| 162–183 | NSGALTSGVHTFPAVLQSSGLY | 47.2 | 1103.5613 (+2) | ||
| 184–201 | SLSSVVTVPSSSLGTQTY | 37.2 | 906.9647 (+2) | ||
| Light | 71–86 | TLTISSLQPDDFATYY | 47.8 | 917.9414 (+2) | |
| 86–95 | YCFQGSGYPF | 36.3 | 1225.4990 (+1) | ||
| 87–95 | CFQGSGYPF | 32.4 | 1062.4354 (+1), 531.7214 (+2) | ||
| Semitryptic | Heavy | 6–18 | ESGPALVKPTQTL | 30.0 | 1340.7430 (+1), 670.8743 (+2) |
| 6–24 | ESGPALVKPTQTLTLTCTF | 44.2 | 1032.5341 (+2), 688.6931 (+3) | ||
| 6–27 | ESGPALVKPTQTLTLTCTFSGF | 49.8 | 1178.0945 (+2), 785.7338 (+3) | ||
| 6–38 | ESGPALVKPTQTLTLTCTFSGFSLSTAGMSVGW | 60.9 | 1716.3461 (+2), 1144.5663 (+3) | ||
| 25–40 | SGFSLSTAGMSVGWIR | 48.2 | 1655.8196 (+1), 828.4121 (+2), 552.6110 (+3) | ||
| 28–40 | SLSTAGMSVGWIR | 39.6 | 1364.6995 (+1), 682.8528 (+2), 455.5711 (+3) | ||
| 39–45 | IRQPPGK | 11.0 | 795.4828 (+1), 398.2450 (+2) | ||
| 46–55 | ALEWLADIWW | 19.6 | 1302.6418 (+1), 651.8240 (+2), 434.8851 (+3) | ||
| 84–95 | VTNMDPADTATY | 24.1 | 1298.5563 (+1), 649.7821 (+2) | ||
| 84–96 | VTNMDPADTATYY | 27.9 | 1461.6192 (+1), 731.3139 (+2) | ||
| 96–99 | YCAR | 9.1 | 569.2501 (+1), 285.1286 (+2) | ||
| 106–124 | YFDVWGQGTTVTVSSASTK | 37.5 | 1017.4943 (+2) | ||
| 151–161 | DYFPEPVTVSW | 47.5 | 1339.6217 (+1), 670.3137 (+2) | ||
| 151–183 | DYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLY | 60.4 | 1763.8600 (+2), 1176.2424 (+3), 882.4336 (+4) | ||
| 151–201 | DYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTY | 66.0 | 1774.2085 (+3), 1330.9107 (+4), 1065.9287 (+5) | ||
| 162–213 | NSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTK | 55.3 | 1798.2434 (+3), 1348.9343 (+4), 1079.3483 (+5) | ||
| 184–213 | SLSSVVTVPSSSLGTQTYICNVNHKPSNTK | 35.5 | 1603.3126 (+2), 1069.2094 (+3), 802.1594 (+4) | ||
| 184–216 | SLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDK | 34.5 | 1774.4087 (+2), 1183.2745 (+3), 887.7074 (+4) | ||
| 202–213 | ICNVNHKPSNTK | 11.1 | 1411.7106 (+1), 706.3584 (+2), 471.2417 (+3), 353.6830 (+4) | ||
| 217–245 | RVEPKSCDKTHTCPPCPAPELLGGPSVFL | 35.5 | 1625.2948 (+2), 1083.8637 (+3) | ||
| 222–244 | SCDKTHTCPPCPAPELLGGPSVF | 43.8 | 1264.0719 (+2), 843.0508 (+3) | ||
| 226–244 | THTCPPCPAPELLGGPSVF | 45.6 | 1018.9829 (+2), 679.6586 (+3) | ||
| 245–251 | LFPPKPK | 21.4 | 826.5180 (+1), 413.7627 (+2), 276.1775 (+3) | ||
| 310–320 | TVLHQDWLNGK | 28.5 | 1310.6865 (+1), 655.8463 (+2), 437.5666 (+3) | ||
| 348–352 | EPQVY | 17.4 | 635.3033 (+1), 318.1553 (+2) | ||
| 353–363 | TLPPSREEMTK | 17.9 | 1288.6549 (+1), 644.8307 (+2) | ||
| 396–408 | TTPPVLDSDGSFF | 44.0 | 1382.6441 (+1), 691.8267 (+2) | ||
| 396–410 | TTPPVLDSDGSFFLY | 51.3 | 1658.7946 (+1), 829.9006 (+2) | ||
| 409–412 | LYSK | 10.2 | 510.2923 (+1) | ||
| 420–426 | WQQGNVF | 29.4 | 878.4145 (+1), 439.7112 (+2) | ||
| 420–439 | WQQGNVFSCSVMHEALHNHY | 37.0 | 1222.5369 (+2), 815.3601 (+3) | ||
| 427–442 | SCSVMHEALHNHYTQK | 21.1 | 1941.8709 (+1), 971.4370 (+2), 647.9609 (+3) | ||
| Light | 29–34 | VGYMHW | 30.9 | 792.3498 (+1), 396.6786 (+2) | |
| 29–35 | VGYMHWY | 33.5 | 955.4126 (+1), 478.2100 (+2) | ||
| 35–41 | YQQKPGK | 9.2 | 848.4616 (+1), 424.7343 (+2) | ||
| 35–44 | YQQKPGKAPK | 10.1 | 1144.6483 (+1), 572.8273 (+2) | ||
| 61–70 | FSGSGSGTEF | 22.3 | 975.4041 (+1) | ||
| 61–85 | FSGSGSGTEFTLTISSLQPDDFATY | 53.3 | 1314.6021 (+2), 876.7387 (+3) | ||
| 61–86 | FSGSGSGTEFTLTISSLQPDDFATYY | 55.2 | 1396.1324 (+2), 931.0921 (+3) | ||
| 61–95 | FSGSGSGTEFTLTISSLQPDDFATYYCFQGSGYPF | 61.4 | 1917.8441 (+2), 1278.8977 (+3) | ||
| 86–102 | YCFQGSGYPFTFGGGTK | 39.1 | 1873.8233 (+1), 937.4132 (+2) | ||
| 87–102 | CFQGSGYPFTFGGGTK | 35.7 | 1710.7601 (+1), 855.8825 (+2), 570.9245 (+3) | ||
| 96–102 | TFGGGTK | 11.6 | 667.3405 (+1), 334.1739 (+2) | ||
| 108–115 | TVAAPSVF | 32.0 | 791.4288 (+1), 396.2183 (+2) | ||
| 116–125 | IFPPSDEQLK | 27.0 | 1173.6152 (+1), 587.3108 (+2) | ||
| 149–172 | VDNALQSGNSQESVTEQDSKDSTY | 21.3 | 1301.5702 (+2), 868.0503 (+3) | ||
| 149–178 | VDNALQSGNSQESVTEQDSKDSTYSLSSTL | 32.1 | 1595.7279 (+2), 1064.1545 (+3) | ||
| 169–172 | DSTY | 9.7 | 485.1877 (+1) | ||
| 169–178 | DSTYSLSSTL | 30.5 | 1073.4993 (+1), 537.2533 (+2) | ||
| 173–182 | SLSSTLTLSK | 28.0 | 1036.5891 (+1), 518.7982 (+2) | ||
| 175–182 | SSTLTLSK | 28.0 | 836.4731 (+1) | ||
| 192–206 | ACEVTHQGLSSPVTK | 20.9 | 1613.7978 (+1), 807.4016 (+2), 538.6037 (+3) |
RT = retention time.
Fig 3(A) Level of nonspecific cleavages as represented by the sum of XICs of the 52 NISTmAb semitryptic peptides and 6 nontryptic peptides relative to the sum of total identified peptides XICs as a function of trypsin resuspension time at room temperature (20°C). Dramatic differences were observed between the two conditions (i.e., 50 mM acetic acid and water); reconstitution in the acidic condition caused more nontryptic cleavages, the extent of which increased with longer reconstitution times. In contrast, the level of nonspecific cleavages remained consistent at approximately 1% with reconstitution of trypsin in water. (B) Evaluation of level of Trypsin-1 nonspecific cleavages under the recommended storage condition, with trypsin reconstituted in 50 mM acetic acid and stored at –80°C for different periods, versus the storage condition using water for reconstitution. The yield of nonspecific cleavages under the recommended storage condition (50 mM acetic acid) was significantly higher and increased with the length of the storage period. (C) Demographic profile of amino acids involved in the semitryptic and nontryptic cleavages, based on 220 semitryptic peptides and 34 nontryptic peptides involving five biotherapeutic samples in addition to NISTmAb.
Overview of the eight commercial trypsins.
| Name | Vendor | Catalog no. | Source | Recommended Reconstitution* |
|---|---|---|---|---|
| Trypsin-1 | Promega | V5280 | Porcine | 50 mM acetic acid |
| Trypins-2 | Promega | V5111 | Porcine | 50 mM acetic acid |
| Trypsin-3 | G-Biosciences | 786–245 | Porcine | 50 mM acetic acid |
| Trypsin-4 | G-Biosciences | 786-245B | Bovine | 50 mM acetic acid |
| Trypsin-5 | Princeton Separations | EN-151 | Porcine | Water |
| Trypsin-6 | Roche | 11418025001 | Bovine | 1% acetic acid or 1 mM HCl |
| Trypsin-7 | Pierce | 90057 | Porcine | 50 mM acetic acid |
| Trypsin-8 | Sigma | T-6567 | Porcine | 1 mM HCl |
*Recommended reconstitution condition is based on product instruction of each trypsin
Fig 4Relative abundance of selected NISTmAb semitryptic peptides for evaluation of nonspecific cleavages.
Shown are (A) heavy chain 151–183, (B) heavy chain 184–213, (C) light chain 61–86, and (D) light chain 87–102, as generated from tryptic digestion with eight commercial trypsins (Trypsin-1 to Trypsin-8). Each trypsin was reconstituted in 50 mM acetic acid (white bar) and HPLC-grade water (gray bar) at room temperature for 4 h before immediate use for digestion.